Quick Answer
Arbutus Biopharma Corp reported Total Assets of $94.62 million for fiscal year 2025.
Arbutus Biopharma Corp Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $94.62M | -28.2% |
| 2024 | $131.71M | -8.8% |
| 2023 | $144.40M | -26.1% |
| 2022 | $195.42M | -4.4% |
| 2021 | $204.49M | +49.2% |
| 2020 | $137.08M | +29.9% |
| 2019 | $105.53M | -53.7% |
| 2018 | $227.91M | -3.9% |
| 2017 | $237.16M | -14.0% |
| 2016 | $275.92M | -61.3% |
| 2015 | $712.29M | +502.7% |
| 2014 | $118.18M | +64.8% |
| 2013 | $71.72M | +36.4% |
| 2012 | $52.60M | +275.9% |
| 2011 | $13.99M | -33.4% |
| 2010 | $21.02M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $97.71M | -30.4% | -5.4% |
| June 30, 2025 | $103.27M | -35.5% | -11.7% |
| March 31, 2025 | $117.01M | -22.1% | -11.2% |
| December 31, 2024 | $131.71M | -8.8% | -6.2% |
| September 30, 2024 | $140.44M | -11.5% | -12.2% |
| June 30, 2024 | $160.04M | -9.5% | +6.5% |
| March 31, 2024 | $150.29M | -21.4% | +4.1% |
| December 31, 2023 | $144.40M | -26.1% | -9.0% |
- Arbutus Biopharma Corp showed a decrease of -28.2% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, Arbutus Biopharma Corp’s total assets has grown by 350.1% (from $21.02 million to $94.62 million).
- The most recent figure is from Arbutus Biopharma Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: